¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"performic acid reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • counter reaction
    ¿ª¹ÝÀÀ
  • coupled reaction
    °ø¿ª¹ÝÀÀ, ¦Áø¹ÝÀÀ, ¿¬°á¹ÝÀÀ
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cutaneous drug reaction
    ÇǺξ๰¹ÝÀÀ
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cytotoxic reaction
    ¼¼Æ÷µ¶¼º¹ÝÀÀ
  • cascade reaction
    ¿¬¼Ó´Ü°è¹ÝÀÀ
  • catalytic reaction
    Ã˸ŹÝÀÀ
  • catastrophic reaction
    ÆÄ±¹¹ÝÀÀ
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • cessation reaction
    Á¤Áö¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • cholera red reaction
    ÄÝ·¹¶óÀû»ö¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • downgrading reaction
    ÇÏÇâ¹ÝÀÀ
  • dry reaction
    °Ç½Ä¹ÝÀÀ
  • early reaction
    Á¶±â¹ÝÀÀ
  • elementary reaction
    ±âº»¹ÝÀÀ
  • elevator reaction
    ½Â°­¹ÝÀÀ
  • emergency reaction
    ±ä±Þ¹ÝÀÀ
  • endergonic reaction
    ¿¡³ÊÁöÈí¼ö¹ÝÀÀ
  • endothermic reaction
    Èí¿­¹ÝÀÀ
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • equilibrium reaction
    ÆòÇü¹ÝÀÀ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
  • escape reaction
    µµÇǹÝÀÀ
  • exergonic reaction
    ¹ß¿­¹ÝÀÀ, ¿¡³ÊÁö¹æÃâ¹ÝÀÀ
  • exoergic reaction
    ¿ÜÀιÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • acid value
    »ê°ª, »ê°¡(߫ʤ).
  • acid, dipicolinic
    µðÇÇÄݸ°»ê
  • acid, lipoteichoic
    ÁöÁúŸÀÌÄÚ»ê
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acid, muramic
    ¹Â¶ó¹Í»ê
  • acid, teichoic
    ŸÀÌÄÚ»ê
  • acid, teichuronic
    ŸÀÌÅ¥·Ð»ê
  • acid, ¥â-hydroxymyristic
    º£Å¸ÇÏÀ̵å·Ï½Ã¹Ì¸®½ºÆ¾»ê
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
  • acid-fast stain
    Ç׻꼺 ¿°»ö
  • acid-fast stain
    Ç׻꼺¿°»ö(ù÷ß«àõæøßä)
  • acid<³ª> acidus
    »ê(ß«), »ê¼º(ß«àõ)ÀÇ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • neutral reaction
    ÁßÈ­¹ÝÀÀ(~Úãëë).
  • neutrophilic leukemoid reaction
    È£Áß±¸¼º ¹éÇ÷º´¾ç ¹ÝÀÀ
  • ninhydrin reaction
    ´ÑÈ÷µå¸°¹ÝÀÀ(~Úãëë).
  • nitrosoindol reaction
    ´ÏÆ®·ÎÀε¹¹ÝÀÀ(~Úãëë).
  • nociceptive reaction
    Ä§ÇØ¹ÝÀÀ(~Úãëë).
  • nonspecific reaction
    ºñƯÀ̹ÝÀÀ.
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ.
  • orbicular reaction
    Æó°Ë¹ÝÀÀ(øÍÌ¡Úãëë).
  • orcinol reaction
    ¿À¸£½Ã³î ¹ÝÀÀ(¡­Úãëë).
  • order of reaction
    ¹ÝÀÀÂ÷¼ö(Úãëëó­â¦).
  • organic reaction type
    ±âÁú¼º ¹ÝÀÀÇü(¡­Úãëëúþ).
  • overanxious reaction
    °úºÒ¾È ¹ÝÀÀ(ΦÝÕäÌÚãëë)
  • oxidase reaction
    »êÈ­È¿¼Ò¹ÝÀÀ(¡­Úãëë).
  • pain reaction
    µ¿Åë¹ÝÀÀ(ÔÙ÷ÔÚãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • deoxyguanylic acid
    µ¥¿Á½Ã±¸¾Æ´Ò»ê(ß«)
  • deoxyribonucleic acid
    µ¥¿Á½Ã¶óÀ̺¸ÇÙ»ê(ß«)
  • deoxyribose nucleic acid
    "µ¥¿Á½Ã¶óÀ̺¸½º ÇÙ»ê(ú·ß«), (ÔÒ) deoxyribonucleic acid"
  • deoxythymidylic acid
    "µ¥¿Á½ÃŸÀ̵̹ô»ê(ß«), (ÔÒ) thymidylic acid"
  • deoxyuridylic acid
    µ¥¿Á½ÃÀ¯¸®µô»ê
  • deuridylic acid
    Å»(÷­)À¯¸®µô »ê(ß«)
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • "2,4-dichlorophenoxyacetic acid"
    "2,4-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,6-dichlorophenoxyacetic acid"
    "2,6-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,5-dihydroxyphenylacetic acid"
    "2,5-ÀÌ(ì£)ÇÏÀ̵å·Ï½ÃÆä´Ò¾Æ¼¼Æ®»ê(ß«) (ÔÒ) homogentisic acid"
  • dinitrophenyl amino acid
    ÀÌ(ì£)´ÏÆ®·ÎÆä´Ò ¾Æ¹Ì³ë»ê(ß«)
  • "1,3-diphosphoglyceric acid"
    "1,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 1,3-bisphosphoglycerate"
  • "2,3-diphosphoglyceric acid"
    "2,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 2,3-bisphosphoglycerate"
  • dipicolinic acid
    µðÇÇÄݸ®´Ñ»ê(ß«)
  • diprotic acid
    À̾çÀÚ »ê(ì£åÕí­ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ASSR adult situation stress reaction
BFPR biologic false-positive reaction
BFR biologic false reaction; blood flow rate; bone formation rate; buffered Ringer [solution]
BRT Brook reaction test
BW bacteriological warfare; bed wetting; below waist; biological warfare; biological weapon; birth weig...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
DER disulfiram ethanol reaction
EAR early asthmatic reaction
EPR early phase reaction
HR hypersensitive reaction
IAR immediate asthmatic reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metaphosphoric acid
    ¸ÞŸÀλê
    ÀλêÀÇ Çϳª. Çü»óÀ¸·Î º¸¾Æ À¯¸®»ó ÀÎ»ê ¶Ç´Â ºù»ó ÀλêÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ½Ä HPO. ¹Ì»ý¹°, °ïÃæ·ù ¶Ç´Â ¾î¶² Á¾·ùÀÇ µ¿¹°ÀÇ Á¶Á÷ µî¿¡ Á¸ÀçÇÑ´Ù. ¹«»ö Åõ¸íÇÑ À¯¸®»ó °íü ¶Ç´Â ºÎµå·¯¿î ºñ´Ü½Ç ¸ð¾çÀÇ ±«»ó ¹°Áú·Î, ºÐÀÚ·® 79.98, ºñÁß 2.2ÀÌ´Ù. Á¶ÇؼºÀ̸ç, ½ÀÇÑ °ø±â ¼Ó¿¡ ¹æÄ¡ÇÏ¸é ¿À¸£Åä Àλê HPO°¡ µÈ´Ù. ¹°, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. °¡¿­ÇÏ¸é ¿ëÀ¶ÇÏ¿© Á¡¼ºµµ°¡ Áõ°¡ÇÏ°í ´õ¿í °¡¿­ÇÏ¸é ½ÂÈ­ÇÑ´Ù. ¼ö¿ë¾× ¼Ó¿¡¼­´Â ÁßÇÕü¸¦ Àß ¸¸µé°í, °£´ÜÇÑ °Íµµ »ïÇÕü³ª »çÇÕü°¡ µÇÁö¸¸, Àå½Ã°£ ¹æÄ¡ÇÏ¸é ¿À¸£ÅäÀλêÀ¸·Î º¯ÇÑ´Ù. ¸ÞŸÀÎ»ê ¿ë¾×¿¡ Áú»ê Àº ¿ë¾×À» °¡ÇÏ¸é ¹é»ö ħÀüÀÌ »ý±ä´Ù. ¸ÞŸÀλêÀº ¿À¸£ÅäÀÎ»ê ¶Ç´Â ÇÇ·ÎÀλê HPOÀ» 300 ¡É ÀÌ»óÀ¸·Î °¡¿­ÇÏ¸é »ý±ä´Ù. 2HPO 2j HPO+HO HPO 2j 2HPO+HO ¶Ç ¿À»êÈ­ÀÎÀ» 0 ¡É ÀÌÇÏ·Î ¼öÈ­ÇØµµ ¾ò´Â´Ù. Ä¡°ú¿ë ½Ã¸àÆ® , È­Çкм®¿ë ½Ã¾à, º¸ÀÏ·¯ ûÁ¤Á¦, ÀμâÁ¦ÆÇ, °¡Á×ÀÇ ¹«µÎÁú µî¿¡ ¾²À̸ç, Ä®·ý¿°Àº À¯Á¦Ç°ÀÇ Á¡¼ºµµ Áõ°¡Á¦, ¼¼Á¦, ÇÜ, ¼Ò½ÃÁöÀÇ Ã·°¡Á¦·Î »ç¿ëµÈ´Ù. ¶ÇÇÑ, ¸ÞŸÀλêÀº »ý¹°ÇлóÀ¸·Îµµ ¸Å¿ì Èï¹Ì·Î¿î ¼ºÁúÀ» °¡Áö°í Àִµ¥, È¿¸ð¿¡¼­´Â ÇÙ»êÀÇ ÇÕ¼º¿¡ ÇÊ¿äÇÑ Àΰú ¿¡³ÊÁö¸¦ ¸ÞŸÀλêÀÌ °ø±ÞÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • methacrylic acid
    ¸ÞŸ ¾ÆÅ©¸¯ »ê
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
late reaction A local or generalised response that begins 24 to 48 hours after exposure to an antigen.
See: cell-mediated reaction.
Synonym: contact hypersensitivity, delayed hypersensitivity, late reaction, tuberculin-type hypersensitivity.
(05 Mar 2000)
fragment reaction A reaction used to assay the activity of peptidyl transferase.
(05 Mar 2000)
Frei-Hoffmann reaction <investigation> A clinical test where dead disease-causing microbes are injected into the skin to see if this causes a skin reaction. It indicates whether the patient is infected with the the injected microbe and is not used commonly.
(07 Apr 1998)
fright reaction After section and degeneration of the facial nerve of an animal, the denervated facial muscles contract if the animal is frightened or becomes angry; due to the release of acetylcholine into the circulation.
(05 Mar 2000)
lengthening reaction In the decerebrate animal, the rather sudden relaxation with lengthening of the extensor muscles when a limb is passively flexed; associated with clasp-knife spasticity.
(05 Mar 2000)
fuchsinophil reaction The property possessed by certain elements, when stained with acid fuchsin, of retaining the stain when treated with picric acid alcohol.
(05 Mar 2000)
lepromin reaction A delayed hypersensitivity reaction at the site of an intradermal injection of a lepromin, such as the Dharmendra antigen or Mitsuda antigen, in a lepromin test; the reaction's, such as the Fernandez or Mitsuda reaction, are variable, occurring in 48 hours or three to five weeks, but are uniformly negative in lepromatous leprosy, borderline leprosy, and mid-borderline leprosy.
(05 Mar 2000)
furfurol reaction Production of a red colour on addition of furfurol to a solution of aniline.
(05 Mar 2000)
leukemoid reaction A benign blood picture resembling leukaemia. For example, in infectious mononucleosis.
(12 Dec 1998)
lid-closure reaction A constriction of both pupils when an effort is made to close eyelids forcibly held apart. A variant of the pupil response to near vision.
Synonym: Galassi's pupillary phenomenon, Gifford's reflex, lid-closure reaction, orbicularis phenomenon, orbicularis pupillary reflex, Piltz sign, Westphal's pupillary reflex, Westphal-Piltz phenomenon.
(05 Mar 2000)
ligase amplification reaction <molecular biology> Method for detecting small quantities of a target DNA, with utility similar to PCR. It relies on DNA ligase to join adjacent synthetic oligonucleotides after they have bound the target DNA. Their small size means that they are destabilised by single base mismatches and so form a sensitive test for the presence of mutations in the target sequence.
(18 Nov 1997)
light dependent reaction The reaction taking place in the chloroplast in which the absorption of a photon leads to the formation of ATP and NADPH.
(18 Nov 1997)
local anaesthetic reaction A toxic reaction due to absorption of local anaesthetic drug during regional anaesthesia, ranging from drowsiness to convulsions and cardiovascular collapse.
(05 Mar 2000)
local reaction A reaction which occurs at the point of entrance of an infecting organism or of an injection, as in the Arthus phenomenon.
Synonym: local reaction.
(05 Mar 2000)
Loewenthal's reaction The agglutinative reaction in relapsing fever.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á